NCT05602922

Brief Summary

In this study, a prospective, randomized controlled method was adopted, with patients with post-stroke dysphagia as the main research objects, applying "Liu-Zi-Jue" to the patients for rehabilitation intervention, and to explore the effect of "Liu-Zi-Jue" on the swallowing function of patients with post-stroke dysphagia. In order to provide a safe and effective TCM treatment plan for patients with dysphagia after stroke, reduce the disability rate after stroke and improve the quality of life of patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 2, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

November 2, 2022

Status Verified

November 1, 2022

Enrollment Period

1.7 years

First QC Date

September 25, 2022

Last Update Submit

November 1, 2022

Conditions

Keywords

strokedysphagiarehabilitationLiu-Zi-Jue Exercise

Outcome Measures

Primary Outcomes (1)

  • Rate of Change in Standardized Swallowing Assessment

    The scale consists of 3 parts, the first part includes the overall evaluation of the patient\'s consciousness, lip closure control, head and trunk control, breathing pattern, soft palate movement, posterior function, gag reflex, spontaneous cough, etc., with a total of 8-23 points; Part 2: Let the patient drink 5ml of water, repeat 3 times, observe the water flow at the corners of the mouth when drinking water, laryngeal movement during swallowing, repeated swallowing, wheezing and laryngeal function, a total of 5 to 11 points; in the second part, if 2 or more times swallowing is normal Then carry out the third part of the assessment: the patient drinks 60 ml of water, and observes the drinking and swallowing, with a total of 5 to 12 points. The total score of this scale is 18-46 points, and the higher the score, the worse the swallowing function.

    Baseline, 4 weeks and 60 days

Secondary Outcomes (5)

  • Video fluoroscopic swallowing study

    Baseline and 4 weeks

  • The volume viscosity swallow test

    Baseline and 4 weeks

  • Penetration-aspiration scale

    Baseline and 4 weeks

  • Water swallow test

    Before treatment, after 4 weeks of treatment and after 60 days of treatment.

  • Modified Barthel Index

    Baseline, 4 weeks and 60 days

Study Arms (2)

basic treatment+ swallowing rehabilitation treatment

ACTIVE COMPARATOR

Swallowing function training mainly includes indirect training, direct training, and compensatory techniques, once a day for 20 minutes each time. In addition, a low-frequency electric VitalStim swallowing therapy device (produced by Chattanooga, USA) was also used for electrical stimulation therapy. The treatment parameters were 700ms in width, two-way square wave, 0~25mA in amplitude, and 30~80Hz in fixed frequency. The A electrode of channel 1 is placed above the hyoid bone, and the B electrode is placed above the notch on the thyroid cartilage. The channel 2 electrode C and electrode D of the therapeutic apparatus are arranged vertically and equidistantly according to the electrode A and electrode B. After the electrodes are placed, turn on the power. The stimulation intensity is based on the maximum stimulation that the patient can tolerate. 1 time a day, 30min each time, a total of 4 weeks.

Other: Basic treatment +Swallowing rehabilitation training

basic treatment+ swallowing rehabilitation treatment+ Liu-Zi-Jue

EXPERIMENTAL

On the basis of the control group, the Liu-Zi-Jue exercises were performed, including "Xu, He, Hu, Si, Chui, Xi", 6 times each time, 5 times a week, each exercise for 30 minutes, and continuous treatment for 4 weeks.

Combination Product: Liu-Zi-Jue Exercise

Interventions

Liu-Zi-Jue ExerciseCOMBINATION_PRODUCT

Combined with the actual situation of stroke patients, this Liu-Zi-Jue Exercise adopts the sitting position.

basic treatment+ swallowing rehabilitation treatment+ Liu-Zi-Jue

Basic treatment +Swallowing rehabilitation training

basic treatment+ swallowing rehabilitation treatment

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meeting the diagnostic criteria of stroke in traditional Chinese medicine. 2.Meeting the diagnostic criteria of ischemic stroke in Western medicine. 3.Meeting the diagnostic criteria for swallowing disorders. 4.30 ≤ age ≤ 85 years; gender not restricted. 5.Duration of illness ≤ 180 days. 6.Water test at level 3 and above. 7.Voluntary participation in the subject, no serious complications, acceptable and good compliance with Liu-Zi-Jue Exercise treatment.
  • Sign the informed consent form.

You may not qualify if:

  • Patients with true bulbar palsy caused by brainstem encephalitis, motor neuron disease, pontine extension tumor, multiple sclerosis, myasthenia gravis, syringomyelia, etc.
  • Cerebrovascular malformation, trauma, aneurysm, etc.
  • Pregnant or lactating women.
  • Patients with severe primary chronic diseases such as heart, liver, kidney and other organs, as well as endocrine system and hematopoietic system, severe dementia and cognitive impairment (Simple Mental State Scale Examination (MMSE): score \<15 points), severe language comprehension disorder, mentally ill patients.
  • Patients with various bleeding tendency diseases.
  • Patients who are allergic to swallowing contrast drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Affiliated hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, 310000, China

RECRUITING

MeSH Terms

Conditions

StrokeDeglutition Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • RUJIE MA, Doctor

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    STUDY DIRECTOR

Central Study Contacts

RUIJIE MA, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 25, 2022

First Posted

November 2, 2022

Study Start

April 1, 2022

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

November 2, 2022

Record last verified: 2022-11

Locations